News | Information Technology | January 13, 2016

AMA Launches Integrated Innovation Company, Health2047

Silicon Valley studio opens opportunities for physicians to engage in the innovation of products that improve the delivery of care to patients

AMA, Health2047, healthcare innovation company, Silicon Valley

January 13, 2016 — The American Medical Association (AMA) announced that it is investing $15M to become founding partner of a healthcare innovation company — Health2047 Inc. The company will conduct rapid exploration of innovative solutions to the biggest challenges facing the nation’s 1.1 million physicians and the patients they serve.

“Improving the health of the nation is at the core of the AMA's work and Health2047 will build partnerships to create new solutions for physicians and their patients that improve health care delivery and health outcomes,” said AMA Chief Executive Officer and Executive Vice President James L. Madara, M.D., who serves as board chair of Health2047. “Health2047’s product orientation and entrepreneurial DNA will help forge new paths and bring commercial solutions to market faster.”

A stand-alone, for-profit entity, Health2047 is an integrated innovation company that combines strategy, design and venture disciplines, working in partnership with leading companies, physicians and entrepreneurs to improve healthcare. Its new Silicon Valley-based innovation studio will draw upon the AMA’s deep subject matter expertise and the organization’s relationship with physicians nationwide to develop new products, tools and resources that improve the practice of medicine and the delivery of healthcare to patients. Health2047 will collaborate with AMA content experts across a wide range of medical, health policy and pragmatic practice areas. It will also integrate healthcare companies, technology companies and entrepreneurs to co-develop, create and spin out offerings that can have large scale, systemic impact on healthcare and medical practice.

Recently the AMA has integrated innovation into its work, resulting in internally generated physician-oriented digital tools as well as targeted engagement of healthcare startups.

“Our investment in Health2047 tangibly underscores the AMA’s ongoing commitment to innovation and collaboration in health care. This dynamic new environment will include the physician perspective in every major innovation cycle, ensuring that physicians play a greater role in leading changes that will move healthcare forward,” said Madara.

For more information: www.health2047.com


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now